• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problems Positioning Failure (1158); Off-Label Use (1494)
Patient Problem Atrial Flutter (1730)
Event Date 05/01/2019
Event Type  Injury  
Event Description
This is filed to report atrial flutter requiring intervention.This research article was a prospective study designed to evaluate the use of transcatheter edge-to edge repair (teer) as a safer and effective alternative to surgery in high risk patients with systemic tricuspid regurgitation (str).Complications identified in the study included positioning failure, off label use, atrial perforation, atrial flutter and unexpected medical intervention.In conclusion, percutaneous teer for str appears to be feasible, safe, and effective.Details are listed in the attached article "percutaneous edge-to-edge tricuspid repair in patients with systemic right ventricle".
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Dates estimated.The udi number is not known as the part and lot numbers were not provided.Medical device code (b)(4).The additional complications referenced will be filed under a separate medwatch report number pertaining to the steerable guide catheter.Attachment: article titled, "percutaneous edge-toedge tricuspid repair in patients with systemic right ventricle.".
 
Manufacturer Narrative
The products were not returned for analysis.The lot history record (lhr) review and similar complaint review were not performed because this complaint was based on a review article, and no device/lot information was provided.Based on the limited information provided, a cause for the reported positioning failure could not be determined.It should be noted that the mitraclip g4 system instructions for use states under the "1.0 intended use" section that "the mitraclip g4 system is intended for reconstruction of the insufficient mitral valve through tissue approximation.¿ the reported off-label use was due to the user performing the mitraclip procedure on the tricuspid valve.Atrial flutter is listed in the instructions for use as a known possible complication associated with mitraclip procedures.A cause for atrial flutter could not be determined.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16279355
MDR Text Key308573107
Report Number2135147-2023-00354
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/10/2023
Initial Date FDA Received02/01/2023
Supplement Dates Manufacturer Received02/02/2023
Supplement Dates FDA Received02/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age41 YR
Patient SexMale
-
-